RESEARCH Open Access Alzheimer disease pathology and the cerebrospinal fluid proteome Loïc Dayon1* , Antonio Núñez Galindo1, Jérôme Wojcik2, Ornella Cominetti1, John…
Multimodal Biomarkers for Alzheimer’s disease Candidates versus genomics and proteomics Research collaborations relevant to biomarkers for AD: • Proteome Sciences Millipore…
Proc. Nati. Acad. Sci. USA Vol. 91, pp. 8378-8382, August 1994 Neurobiology Relative abundance of Alzheimer Af3 amyloid peptide variants in Alzheimer disease and normal aging…
Alzheimer’s cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in KoreansRESEARCH Open Access
Blocking the apolipoprotein E/amyloid-� interaction as a potential therapeutic approach for Alzheimer’s disease Martin J. Sadowski*†‡, Joanna Pankiewicz*, Henrieta…
CEN Outreach Neurological Disorders Migraine, Mul,ple Sclerosis, Alzheimer’s Disease Migraine • Migraine is the most common neurological disorder…
Perspectives in Alzheimer Science 2 perspectives in alzheimer science Research Highlights: Discoveries underscore the predictive value of biomarkers and the potential influence…
Proc Natl Acad Sci USA Vol 92 pp 4299-4303 May 1995 Medical Sciences Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic…
Neuroscience & Medicine, 2011, 2, 397-409 doi:10.4236/nm.2011.24053 Published Online December 2011 (http://www.SciRP.org/journal/nm) Copyright © 2011 SciRes. NM 397…
Neurosci Bull December 1, 2014, 30(6): 923–935. http://www.neurosci.cn DOI: 10.1007/s12264-014-1479-3 923 ·Original Article· Humanin attenuates Alzheimer-like cognitive…
F E A T U R E D B A S I C S C I E N C E A R T I C L E Antibody-Based In Vivo PET Imaging Detects Amyloid-b Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition…
LUND UNIVERSITY PO Box 117 221 00 Lund +46 46-222 00 00 Fluid biomarkers in Alzheimers disease - current concepts Rosen, Christoffer Hansson, Oskar Blennow, Kaj Zetterberg,…
IL-33 ameliorates Alzheimer’s disease-like pathology and cognitive decline Amy K Y Fuabc Kwok-Wang Hungabc Michael Y F Yuenabc Xiaopu Zhouabc Deejay S Y Makabc Ivy C W…
ARTICLE OPEN ACCESS CLASS OF EVIDENCE ABBY A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease Jeffrey L. Cummings, MD, ScD, Sharon Cohen, MD,…
REVIEW Amyloid Beta and Tau as Alzheimer’s Disease Blood Biomarkers: Promise From New Technologies Lih-Fen Lue . Andre Guerra . Douglas G. Walker Received: February 9,…
Review Article CSF Biomarkers of Alzheimer’s Disease: Impact on Disease Concept Diagnosis and Clinical Trial Design Anne M Fagan Department of Neurology Knight Alzheimer’s…
SAGE-Hindawi Access to Research International Journal of Alzheimer’s Disease Volume 2010, Article ID 978182, 7 pages doi:10.40612010978182 Review Article Biological Markers…
1058 http:journalstubitakgovtrmedical Turkish Journal of Medical Sciences Turk J Med Sci 2015 45: 1058-1072 © TÜBİTAK doi:103906sag-1405-96 Potential genetic biomarkers…
Comparison of Alzheimer A�1–40 and A�1–42 amyloid fibrils reveals similar protofilament structures Matthias Schmidta,b,c, Carsten Sachsea,b,1, Walter Richterd, Chen…
A quantitative approach to the use of biomarkers in studying the etiology, natural history, diagnosis and treatment of Alzheimer’s disease: progress in blood-based screens…